Celularity receives notice regarding non-payment of Nasdaq fees
Stay Ahead of the Market:
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Movano to request hearing from Nasdaq
Movano (MOVE) announced that it received a delisting determination from Nasdaq with respect to the $1.00 per share bid price requirement, as set forth in Listing Rule 5550(a)(2), and the late filing requirement, as set forth in Listing Rule 5250(c)(1), given the delay in filing its Form 10-Q for the quarter ended March 31. Accordingly, the company plans to timely submit a request for a hearing before a Nasdaq Hearings Panel. While the hearing request only stays suspension and delisting for 22 calendar days from the date of the Notice, the company intends to request an extended stay, concurrent with the filing of the hearing request through the conclusion of the hearings process and the expiration of any exception period granted by the panel following the hearing. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Yahoo
an hour ago
- Yahoo
Kraft Heinz reportedly plans to split up, spin off grocery business
-- Kraft Heinz (NASDAQ:KHC) Co is preparing to break itself up by spinning off a significant portion of its grocery business, according to a Wall Street Journal report published Friday. The food giant is looking to separate many Kraft products into a new standalone entity that could be valued at up to $20 billion, the report said, citing people familiar with the matter. Following the split, Kraft Heinz would retain its sauce and spread products, including the company's flagship Heinz ketchup and Grey Poupon Dijon mustard. Kraft Heinz shares are gaining over 2.5% following the publication of the WSJ report. Related articles Kraft Heinz reportedly plans to split up, spin off grocery business Air India crash probe reveals pilot cut fuel flow to engines S&P 500 falls after Pulte claims Powell considering resignation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Why Clover Health (CLOV) Shares Are Trading Lower Today
Shares of health insurance company Clover Health (NASDAQ:CLOV) fell 4.8% in the afternoon session after a filing revealed that the company's CEO, Wai Conrad, sold a portion of his holdings. According to a regulatory filing on July 11, 2025, CEO Wai Conrad sold 15,203 shares of Class A Common Stock on July 8 for a total of approximately $49,561. The transactions were made at prices ranging from $3.25 to $3.27 per share. While the sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell a predetermined number of shares at a predetermined time, the news can still create unease among investors. Insider selling, even when planned, is often scrutinized by the market for any signals about a company's future prospects, contributing to negative pressure on the stock price. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Clover Health? Access our full analysis report here, it's free. Clover Health's shares are extremely volatile and have had 45 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Clover Health is down 7.2% since the beginning of the year, and at $2.91 per share, it is trading 39.7% below its 52-week high of $4.82 from January 2025. Investors who bought $1,000 worth of Clover Health's shares 5 years ago would now be looking at an investment worth $261.71. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
